Category Archives: HIV/AIDS

An update on the anti-prostitution pledge

By on .

This question and answer session with Rebekah Diller, the deputy director of the Justice Program at the Brennan Center for Justice at the New York University School of Law, discusses the anti-prostitution pledge faced by grantees of the U.S. President’s emergency Plan for AIDS Relief (PEPFAR). What is the anti-prostitution pledge (also known as the […]

CDC releases interim guidelines on PrEP

By on .

The U.S. Centers for Disease Control and Prevention (CDC) has released interim guidance for the use of antiretroviral medication as pre-exposure prophylaxis (PrEP) for high-risk gay and bisexual men who have sex with men (MSM) in the United States. The guidance was released in this week’s edition of Morbidity and Mortality Weekly Report (MMWR).

“For MSM whose behaviors place them at high risk for HIV infection and who do not use other effective prevention methods consistently, PrEP might reduce their risk for HIV infection” …

Prominent Ugandan human rights activist murdered

By on .

Photo courtesy of the Guardian

David Kato, a prominent human rights activist fighting for the rights of lesbians, gays, bisexuals, transgender and intersex (LGBTI) persons in Uganda, died Wednesday on the way to the hospital after a brutal beating in his home. Witnesses reported to police that a man entered Kato’s home and hit him twice in the head, before escaping the scene in a vehicle.

Across the nation, community groups are coming together to condemn Kato’s killing and calling on the Ugandan government, civil society and local communities to protect sexual minorities. U.S. based advocates are calling on the U.S. government to continue its pressure on the Ugandan government to protect the human rights of sexual minorities…

Profiles of House Republicans key to global health funding

By on .

A tough political environment for global health funding

The new Congress brings about a number of important changes to the U.S. House of Representatives’ Appropriations Subcommittee, which determines most of the funding levels for U.S. global health programs through the State and Foreign Operations Subcommittee. Among other programs, this subcommittee plays a major role in determining annual funding levels for the President’s Emergency Plan for AIDS Relief (PEPFAR) program, global tuberculosis, and the Global Fund to Fight AIDS, TB and Malaria. It can also use the appropriations process to effect policy changes by conditioning the use of funds.

Haiti leans on AIDS program infrastructure to rebuild health system

By on .

[podcast][/podcast] One testimony to the strength of the U.S. government’s AIDS program in Haiti: Four months after the devastating 2010 earthquake, the number of those treated for AIDS was at 95 percent of pre-earthquake levels. In addition, said senior U.S. health officials in a briefing to reporters, the number of pregnant women receiving AIDS treatment […]

Q & A with Dr. Vermund – Reflecting on PEPFAR Scientific Advisory Board Meeting

By on .

Sten Vermund, MD, PhD, professor of medicine and director of the Institute for Global Health at Vanderbilt University School of Medicine, sits on the Scientific Advisory Board (SAB) to the President’s Emergency Plan for AIDS Relief (PEPFAR). The SAB met for two days last week in Washington, DC, reviewing the current portfolio of PEPFAR-funded initiatives, the […]

Abbott denied patent for liponavir/ritonavir HIV drug combo in India

By on .

The Indian patent office denied a drug patent application by U.S. pharmaceutical company Abbott Laboratories for the combination of lopinavir/ritonavir over the weekend, stating that the patenting was “not an invention.” The drug combination is a protease inhibitor used as a second line regimen to treat patients with HIV, and the patent denial opens the […]